Home › Hemoglobinopathies › New York › New York City
Hemoglobinopathies clinical trials in New York City, NY
4 studies for Hemoglobinopathies are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The HOPE Biobank Resource (BMT CTN 2402 HOPE)
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Cancer Center, New York
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
RecruitingPhase 3
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A Long-term Follow-up Study in Patients Who Received BEAM-101
RecruitingObservational study
- Columbia University Irving Medical Center, New York
Hemoglobinopathies trials in other cities
- St. Louis, MO4 studies
- Philadelphia, PA3 studies
- Minneapolis, MN3 studies
- Nashville, TN3 studies
- Memphis, TN3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.